 Abeona Therapeutics Inc. ABEO, a fully-integrated leader in gene and cell therapy, today announced Board of Director appointments that strengthen and expand the Companys leadership. George Migausky and Paul Mann were appointed as independent directors, effective June 17, 2020. In addition to their Board service, Mr. Migausky will serve as Chairman of the Companys Audit Committee and Mr. Mann will serve as a member of the Audit Committee. 